GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Accelerate Diagnostics Inc (STU:1A80) » Definitions » Market Cap

Accelerate Diagnostics (STU:1A80) Market Cap : €31.33 Mil (As of Dec. 14, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Accelerate Diagnostics Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Accelerate Diagnostics's share price for the quarter that ended in Sep. 2024 was €1.5. Accelerate Diagnostics's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 24.89 Mil. Therefore, Accelerate Diagnostics's market cap for the quarter that ended in Sep. 2024 was €37.33 Mil.

Accelerate Diagnostics's quarterly market cap increased from Mar. 2024 (€19.63 Mil) to Jun. 2024 (€24.15 Mil) and increased from Jun. 2024 (€24.15 Mil) to Sep. 2024 (€37.33 Mil).

Accelerate Diagnostics's annual market cap declined from Dec. 2021 (€293.60 Mil) to Dec. 2022 (€56.24 Mil) and declined from Dec. 2022 (€56.24 Mil) to Dec. 2023 (€52.45 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Accelerate Diagnostics's Enterprise Value for Today is €67.67 Mil.


Accelerate Diagnostics Market Cap Historical Data

The historical data trend for Accelerate Diagnostics's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerate Diagnostics Market Cap Chart

Accelerate Diagnostics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 820.63 339.89 293.60 56.24 52.45

Accelerate Diagnostics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 70.49 52.45 19.63 24.15 37.33

Competitive Comparison of Accelerate Diagnostics's Market Cap

For the Medical Devices subindustry, Accelerate Diagnostics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Accelerate Diagnostics's Market Cap Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Accelerate Diagnostics's Market Cap distribution charts can be found below:

* The bar in red indicates where Accelerate Diagnostics's Market Cap falls into.



Accelerate Diagnostics Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Accelerate Diagnostics's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=€3.6*14.5695
=€52.45

Accelerate Diagnostics's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )=Share Price (Q: Sep. 2024 )*Shares Outstanding (EOP) (Q: Sep. 2024 )
=€1.5*24.8868
=€37.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Accelerate Diagnostics  (STU:1A80) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Accelerate Diagnostics Market Cap Related Terms

Thank you for viewing the detailed overview of Accelerate Diagnostics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Accelerate Diagnostics Business Description

Traded in Other Exchanges
Address
3950 South Country Club Road, Suite 470, Tucson, AZ, USA, 85714
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.

Accelerate Diagnostics Headlines

No Headlines